The recent hypothesis that postnatal microglia are maintained independently of circulating monocytes by local precursors that colonize the brain before birth has relevant implications for the treatment of various neurological diseases, including lysosomal storage disorders (LSDs), for which hematopoietic cell transplantation (HCT) is applied to repopulate the recipient myeloid compartment, including microglia, with cells expressing the defective functional hydrolase. By studying wild-type and LSD mice at diverse time-points after HCT, we showed the occurrence of a short-term wave of brain infiltration by a fraction of the transplanted hematopoietic progenitors, independently from the administration of a preparatory regimen and from the presence of a disease state in the brain. However, only the use of a conditioning regimen capable of ablating functionally defined brain-resident myeloid precursors allowed turnover of microglia with the donor, mediated by local proliferation of early immigrants rather than entrance of mature cells from the circulation.
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M icroglia are the resident immune cells of the central nervous system (CNS) and belong to the mononuclear phagocyte lineage (1) . Currently, they are believed to originate from ontogenically distinct primitive myeloid progenitors that during the embryonic stage invade the developing brain, where they transform into the resting ramified microglia of the mature CNS (2) . Different hypotheses exist about how microglia are maintained in adulthood: it was proposed that microglia only self-renew themselves via in situ proliferation from resident progenitors, but also that their pool is replenished from circulating progenitors. Several in vitro (3, 4) and in vivo (5-9) studies addressed this issue, and most recent literature suggested that postnatal microglia are maintained independently of circulating monocytes by local radio-resistant precursors that colonize the brain before birth (2) . Such evidence has relevant implications for the treatment of various neurological disorders, including lysosomal storage disorders (LSDs).
Over the past three decades, ∼1,000 hematopoietic cell transplantations (HCTs) have been performed worldwide for patients with different LSDs in the attempt to slow the course of the disease, prevent symptoms onset, and improve pathological findings (10) (11) (12) . The aim of HCT in these disorders is to repopulate the recipient myeloid compartment, including microglia, with cells expressing the hydrolase that is defective in the recipient (13) . Because macrophage and microglia represent the major effectors of the catabolism of the storage material throughout the tissues, their replacement by normal cells restores a critical scavenging function. Moreover, these cells can secrete a portion of their lysosomal enzymes, which can be taken up by neighboring cells, which are thus corrected in their metabolic defect (13) . From the impressive results obtained in Hurler syndrome (11) , it was expected that most LSDs could be alleviated by HCT. However, HCT proved to be ineffective in LSD patients with severe CNS involvement and, in particular, in those having overt neurological symptoms and/or aggressive early onset forms (10) . The main reason for HCT failure in these patients is likely the slow pace of replacement, if any, of resident CNS microglia by the transplanted hematopoietic cell progeny, compared with the rapid progression of the primary neurological disease. Indeed, although the reconstitution of visceral organ macrophages by donor-derived cells has been clearly established after HCT, substantial debate (8, 9) and poor knowledge exist on the actual occurrence, modalities, and timing of CNS microglia replacement by the progeny of the transplanted hematopoietic cells.
Here, we used a multidisciplinary approach to study the brain myeloid compartment of wild-type (WT) and LSD mice at diverse time-points after HCT and provide evidence of extensive bona fide microglia reconstitution only upon (i) migration and engraftment in the brain of donor cells capable of intraparenchymal proliferation and (ii) pharmacological ablation of an endogenous proliferating myeloid cell pool, which could likely contribute to microglia maintenance in physiological conditions.
Results
Donor Myeloid Infiltration Occurs in the Brain of Naïve Mice. We used a multidisciplinary approach based on magnetic resonance imaging (MRI), flow cytometry, and immunohistology to monitor the fate of hematopoietic stem and progenitor cells (HSPCs), retrieved by lineage negative (Lin − ) selection from the murine bone marrow (BM), upon transplantation into naïve congenic recipients. Superparamagnetic iron oxide (SPIO) particles were used for rendering HSPCs detectable by MRI in short-term studies (14, 15) , whereas GFP-encoding lentiviral vectors (LVs) were used to track genetically marked cells long-term (Fig. S1 ). Double-labeled (DL)-HSPCs were i.v. transplanted into naïve, 2-mo-old WT or LSD mice [we used the As2 −/− model of metachromatic leukodystrophy (MLD), a prototypical LSD with CNS involvement] (Fig. S2A) . Short term after HCT, upon mice perfusion, MRI demonstrated multiple hypointense spots within the brain of the tested animals ( Fig. 1 A, C, and F) . Interestingly, the signal was detected only in mice transplanted with c-Kit
+ Lin − cells (KSL; enriched in stem cell activity) and not in animals receiving the not c-Kit + Sca1 + (not KS) Lin − counterpart (Fig. 1C and Fig. S1 E-G). Prussian blue staining, GFP immunofluorescence, and electron microscopy showed iron-containing, GFP + cells in areas consistent to those where MRI detected the hypointense spots ( Fig. 1 B, D , and E). The number of spots detected in WT and MLD mice was similar (Fig. 1 F and G) , whereas a notable difference in the location of the signal in the two groups was observed ( Fig. 1 F and H) , with abundant signal in the corpus callosum of MLD animals, where a delay in myelination is present (16) .
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This article is a PNAS Direct Submission. Analysis of GFP expression within the brain myeloid compartment of the transplanted mice by flow-cytometry confirmed the presence of donor cells short term after HCT ( Fig. 1 I and J) . Long-term analysis up to 15 mo after HCT revealed persistence and limited expansion of these cells, despite their virtual absence from the BM (Fig. 1 I and J) . Both at short-and long-term after HCT, the GFP + cells were round and small hematopoietic lineage cells and expressed at low levels the myeloid markers Iba1 and CD11b ( Fig. 1 K and L) without evidence of mature microglia reconstitution even in the long term (Fig. 1L) . The cells were mostly found in areas of short-term homing, being more abundant in adult neurogenic areas and in the corpus callosum of MLD mice (Fig. 1L) .
To assess the therapeutic potential of the cells engrafted in the brain of naïve mice, we tested the activity of arylsulfatase A (ARSA; the defective enzyme in MLD) in the brain of As2 −/− mice transplanted with WT HSPCs long term after HCT (7). However, no significant increase in ARSA activity could be detected at comparison with untreated MLD littermates (0.9 ± 0.04 fold vs. the untreated As2 −/− mice activity level, n ≥ 3).
Macrophage/Microglia Replacement in the Brain of Preconditioned
Mice. We then assessed whether the administration of a preparative regimen before HCT, allowing for engraftment of the donor cells into hematopoietic organs, could lead to reconstitution of microglia. We compared widely used regimens differing in their capability to cross the blood-brain barrier (BBB) and cause CNS toxicity (7, 17) . In particular, treosulfan (TREO) is the only regimen, among the tested ones, unable to cross the BBB. Pretreated adult WT or MLD mice were transplanted with labeled congenic HSPCs and analyzed as described above (Fig. S2B ). Labeled cells were detected in the brain of transplanted mice by 5 d after HCT, with a similar frequency and location in all of the transplant groups ( Fig. 2A) . At longer time points, once sustained donor chimerism was established in the BM (Fig. S3) , the frequency of GFP + cells within brain myeloid populations differed between the animals according to (i) the time at analysis, (ii) the regimen applied before HCT, and (iii) the CD45 +
CD11b
+ subpopulation considered (18) (19) (20) (Fig. 2 
Analysis of mice transplanted with GFP-LV-labeled KSL cells or not KS Lin
− cells revealed that the KSL fraction is the only HSPC fraction associated to sustained GFP chimerism within brain myeloid cells long-term after transplant (Fig. S5) . GFP
+/low MHC − ramified parenchymal cells, frequently grouped in clusters, were observed at increasing frequency over time in BU mice at confocal analysis ( Fig. 3 and Fig. S6) ; their morphology resembled that of microglia at different stages of maturation (19) (Fig. 3 and Fig. S6 ). GFP + ramified cells were present also in IRR mice, but their appearance in the brain was delayed in time and their morphology less mature ( Fig. 3 and + nonramified cells located at the meninges, perivascular spaces, and plexi ( Fig. 3 and Fig. S6 ). Microglia Reconstitution by the Donor Is Associated to Depletion of the Endogenous Compartment. We then assessed whether the conditioning could have had a direct effect on the endogenous brain myeloid compartment. Flow cytometry revealed a reduction in the frequency of myeloid cells in the brain of BU and IRR mice compared with untreated and TREO animals since 14-45 d after HCT (Fig. S7A ). This reduction was associated to a progressive decline in μ cell relative frequency and to an increase in TAμ cell frequency in the same groups (Fig. 4 A, B, and D) . At confocal analysis, endogenous microglia showed a senescent appearance with deramified morphology, and/or twisted and tortuous/stripped down processes (20) , in BU animals evaluated 45 or more days after HCT (Fig. 4C and Fig. S7) . Interestingly, the extent of μ cell depletion significantly correlated with the GFP chimerism within this same population (Fig. 4 D and E) . These long-term events were associated to the presence of a large fraction of apoptotic Annexin V + cells within CD45 + CD11b + cells (Fig. 4F) and of TUNEL + apoptotic Iba1 + cells (Fig. 4G ) in BU and, at a lower frequency, IRR mice 5-14 d after HCT. Apoptotic cells were negative for GFP and, therefore, bona fide host derived.
A microarray study performed on the whole brain of treated and control mice revealed the TNF-α mRNA to be increased in BU and, with a delayed kinetics, IRR animals short-term after treatment, which confirms the occurrence of apoptosis in these mice (Fig. S8) (21) . Up-regulation of molecules involved in monocyte recruitment was transiently observed in IRR animals, consistent with what was described (Fig. S8) (9, 22) . ) mice for each group at each time point. Mean and minimum/maximum values are shown; *P < 0.05, **P < 0.01, ***P < 0.001 at one-way ANOVA (with Bonferroni's post hoc test). up a two-step transplant protocol in which busulfan and treosulfan were used to sequentially treat mice receiving differentially labeled cells (GFP + vs. ΔNGFR + ) (Fig. S2C) . A transient BM engraftment of GFP + cells, transplanted as first, was observed after busulfan treatment and HCT (Fig. 5A and Fig.  S9B ). By 45 d after the second, treosulfan-mediated HCT, most of the GFP + cells disappeared from the recipients' BM and peripheral blood and sustained BM engraftment of the ΔNGFR + cells was observed ( Fig. 5A and Fig. S9B ). Consistently, liver CD45 + CD11b + cells were mostly ΔNGFR + (Fig.  5A) . On the contrary, the brain myeloid pool was enriched in GFP + cells (Fig. 5A) . The highest GFP/ΔNGFR ratio was observed in μ cells, whereas the lowest was present in CNS-ϕ (Fig.  5A) . A progressive expansion of the donor-derived cells in the brain was observed between days 45 and 180 and it was mostly due to an increased frequency of transgene + μ cells; this expansion was mediated both by GFP + and ΔNGFR + cells (Fig.  5A) . Confocal analysis demonstrated the presence of abundant GFP
+ ramified cells in brains analyzed at 45-180 d after the second HCT (Fig. 5 B-D) . Also, ΔNGFR + Iba1 + CD11b + were found, with a less mature morphology and at lower frequency (Fig. 5 B-D) . A depletion of microglia, having a senescent appearance at confocal analysis, and expansion of TAμ cells were also observed (Fig. S9D) .
To understand how, in the presence of a very low frequency of GFP + cells in peripheral blood, a sustained and dynamically expanding GFP chimerism could be obtained in the brain, we administered 5-ethynyl-2′-deoxiuridine (EdU) before mice killing and quantified proliferation of brain myeloid cells by cytofluorimetry. Interestingly, a larger fraction of proliferating cells was noticed in the transplanted animals compared with untreated age-matched controls (Fig. 5 E and F) . The majority of these cells was of donor origin and composed by GFP + and ΔNGFR + elements in similar proportions (Fig. 5G) . The proliferating cells were mostly contained in the μ population (Fig.  5H) . Confocal analysis confirmed these findings by showing transgene + Ki67 + cells in the brain of transplanted mice both short-and long-term after HCT (Fig. 5I) .
Interestingly, also LV integration site analysis in BU-transplanted animals indicated expansion (likely upon local proliferation) of an oligoclonal cell pool, which migrated short-term into the brain and was maintained independently from the BM HSC pool (Fig. S10 and Table S1 ). Of note, the TAμ cell fraction that is expanded in the transplanted mice is reminiscent of the myeloid cells found in the immature mouse brain (Fig. S11) . Thus, it might represent an immature population, which could give rise in the long-term to mature microglia.
Discussion
A critical need exists to enhance and accelerate microglia turnover with donor cells after HCT to anticipate the time of clinical benefit and improve the efficacy of the transplant in severe diseases like LSDs. For these disorders, reconstitution of microglia with donor-derived elements is of particular value being that these cells are the most abundant among the myeloid brain populations, thus the most valuable source for CNS metabolic correction. However, obtaining microglia reconstitution by the donor is a challenging goal, particularly when clinically predictive settings are used (9) . Moreover, very little is known on the modalities of microglia turnover in physiological and pathological conditions, which may help in adequately designing therapeutic approaches.
The work here presented identifies critical factors, which could be exploited to induce successful microglia reconstitution. Indeed, by challenging different conditioning protocols in mice, we showed that only the use of a regimen, such as busulfan, capable of depleting endogeous microglia, likely through short-term killing of functionally defined precursors, allowed obtaining an efficient turnover of these cells with donor-derived elements. Importantly, the extent of long-term depletion of mature microglia correlated well with the extent of donor chimerism within the same population. Of note, the LSD microglia, which is known to be a site of storage and a critical player in disease neuropathology, is particularly sensitive to this toxic effect, thus providing a direct explanation of the higher donor chimerism observed in LSD models after HCT (Fig. S12) (7, 22) . Interestingly, this concept applies also when a challenging transplant setting is used, such as the sequential transplant protocol here described. In this setting, we could rather strengthen our findings, because the ablative effect exerted by busulfan in the first HCT was strong enough to allow microglia reconstitution also by the cells transplanted after treosulfan. The latter, when used as a single agent, was not capable of inducing microglia replacement. Thus, busulfan was capable of modulating the local brain environment in a favorable manner, likely by creating "space" for the engraftment of ΔNGFR + cells. These findings suggest a unique paradigm in the brain that mimics the concept of myeloablation in the hematopoietic system at the basis of HCT practice-and of its success-for decades. Moreover, they provide hints on the mechanism of microglia maintenance during adulthood upon indirect identification of myeloid cells, which could contain bona fide microglia progenitors, whose ablation results in long-term depletion and senescence of mature microglia.
The double-transplant experiment also allowed obtaining relevant information on the mechanisms of microglia reconstitution: a sustained GFP chimerism was observed in brain myeloid cells, including antigenically and morphologically defined microglia, long-term after HCT even when a very low GFP chimerism was present in BM, peripheral blood, and other tissue macrophages. This finding, together with the identification of donor-derived cells proliferating in the brain long-term after HCT and with the appearance after HCT of progressively more mature donor cells resembling those found during postnatal development (19) , suggest that microglia reconstitution can occur independently from donor engraftment in the BM and recruitment of circulating mature myeloid cells. It could result rather from expansion and maturation of donor-derived precursor cells capable of local proliferation once migrated in the brain short-term after HCT. Of note, the composition of the brain donor-derived cells in the short-term was oligoclonal compared with the BM Lin − and spleen Gr1 + populations and appeared poorly developmentally related to the latter two cell populations.
Interestingly, these findings are in agreement with the recently reported observation that HSCs must be transplanted to obtain microglia turnover with the donor (23) and provide an unexpected mechanistic explanation to this latter observation. Indeed, according to our data, HSCs might be required for obtaining microglia replacement by the donor because they comprise a cell subpopulation able to replace the intraparenchymal microglia precursors that are eliminated upon myeloablative conditioning, rather than because they ensure long-term hematopoietic donor engraftment in the BM. Chemokine receptor 2 (CCR2), which was shown to play a role in microglia reconstitution (9) and to be expressed also in immature hematopoietic subsets such as myeloid progenitors (24) , could be involved in the migration of BM-derived microglia progenitors into the busulfan-conditioned brain, in which the expression of CCR2 ligands is induced (Fig. S8) . This model raises issues that should be addressed in the future. First, a detailed characterization of the cells, which undergo apoptosis short-term after conditioning, is needed. Indeed, these cells may represent or comprise the long-sought, bona fide microglia progenitors, which have been described to migrate into the brain in embryonic life and to maintain the microglia pool during adulthood (2, 8) . Second, the identification of the fraction within KSL cells capable of short-term brain homing and local proliferation would be of great value. Furthermore, a better characterization of the fate of donor-derived cells into the CNS would be of interest, like in the case of TAμ cells, which could represent an immature/transient population that may in the longterm replenish the mature microglia pool. Finally, the findings reported in the sequential transplant setting propose a very provocative scenario in which engraftment in hematopoietic organs might not be necessary for obtaining efficient microglia reconstitution by the donor after HCT. This scenario is consistent with the results obtained in adrenoleukodystrophy (ALD) patients treated by HSC gene therapy (25) . Interestingly, in these patients, clinical benefit, comparable to that described in ALD subjects showing full donor chimerism after allogeneic HCT, was observed despite a bone marrow engraftment of the genetically corrected cells less than 15%. These patients received a busulfan-based conditioning, which could have favored a sustained brain chimerism of the transduced cells, potentially higher than the one detected in the hematopoietic system.
In conclusion, we demonstrate that a short-term wave of brain infiltration by a fraction of the transplanted hematopoietic progenitors occurs upon HCT, independently from the administration of a preparatory regimen and from the presence of a disease state in the brain; the use of a conditioning regimen capable of exerting an ablative effect on functionally defined CNS-resident myeloid precursors favors turnover of microglia with the donor cells, likely mediated by local proliferation of early immigrants. Most importantly, this work has high clinical relevance because it provides valuable suggestions for the design of alternative protocols for patients undergoing HCT or HSC gene therapy in the presence of neurological disorders requiring microglia replacement for therapeutic efficacy, as in the case of LSDs.
Materials and Methods
Mice Studies. Studies were performed on As2 +/+ and As2 −/− mice (26) 
